{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:39:16Z","timestamp":1789756756109,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jcv.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,10,4]],"date-time":"2017-10-04T06:17:07Z","timestamp":1507097827000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir \u2013 Case series and 10 year experience of management in an adult transplant cohort"],"prefix":"10.1016","volume":"96","author":[{"given":"Isobel D.","family":"Ramsay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Attwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Irish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia","family":"Kyriakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcv.2017.09.013_bib0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jcv.2017.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/313514","article-title":"Adenovirus infections in hematopoietic stem cell transplant recipients","volume":"29","author":"Howard","year":"1999","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2017.09.013_bib0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.bmt.1702716","article-title":"Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation","volume":"26","author":"Baldwin","year":"2000","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.jcv.2017.09.013_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1703083","article-title":"Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study","volume":"28","author":"Runde","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.jcv.2017.09.013_bib0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.11279","article-title":"Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome","volume":"92","author":"Robin","year":"2007","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jcv.2017.09.013_bib0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl. Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2017.09.013_bib0035","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2017.09.013_bib0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9343(97)00015-6","article-title":"Adenovirus infections in immunocompromised patients","volume":"3A","author":"Carrigan","year":"1997","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.jcv.2017.09.013_bib0045","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/169.4.775","article-title":"Increasing incidence of adenovirus disease in bone marrow transplant recipients","volume":"169","author":"Flomenberg","year":"1994","journal-title":"J. Infect. Dis."},{"issue":"25","key":"10.1016\/j.jcv.2017.09.013_bib0050","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcv.2017.09.013_bib0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbmt.2012.10.014","article-title":"Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution","volume":"19","author":"Lee","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"11","key":"10.1016\/j.jcv.2017.09.013_bib0060","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1705164","article-title":"Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath)","volume":"36","author":"Myers","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jcv.2017.09.013_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/CJI.0000000000000034","article-title":"First-in-man clinical results with good manufacturing practice (GMP)-compliant polypeptide-expanded adenovirus-specific T cells after haploidentical hematopoietic stem cell transplantation","volume":"37","author":"Geyeregger","year":"2014","journal-title":"J. Immunother."},{"issue":"1","key":"10.1016\/j.jcv.2017.09.013_bib0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/14653249.2011.636963","article-title":"Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus: cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant","volume":"14","author":"Sili","year":"2012","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.jcv.2017.09.013_bib0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.transproceed.2012.06.059","article-title":"Histopathologic resolution of adult liver transplantation adenovirus hepatitis with cidofovir and intravenous immunoglobulin: a case report","volume":"45","author":"Kerensky","year":"2013","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.jcv.2017.09.013_bib0080","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/ndt\/gfg365","article-title":"Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin","volume":"18","author":"Emovon","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.jcv.2017.09.013_bib0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bmt.1703798","article-title":"Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"31","author":"Ljungman","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.jcv.2017.09.013_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","article-title":"Evaluation of Cidofovir (HPMPC: GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model","volume":"31","author":"de Oliveira","year":"1996","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.jcv.2017.09.013_bib0095","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.jcv.2017.09.013_bib0100","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.jcv.2017.09.013_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0166-3542(03)00110-4","article-title":"Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney","volume":"59","author":"Ciesla","year":"2003","journal-title":"Antiviral Res."},{"issue":"20","key":"10.1016\/j.jcv.2017.09.013_bib0110","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1073\/pnas.0800200105","article-title":"Hexadecyloxypropyl-cidofovir: CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model","volume":"105","author":"Toth","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jcv.2017.09.013_bib0115","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1702820","article-title":"Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children","volume":"27","author":"Legrand","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.jcv.2017.09.013_bib0120","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/jmv.10382","article-title":"Rapid and quantitative detection of human adenovirus DNA by real-time PCR","volume":"70","author":"Heim","year":"2003","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2017.09.013_bib0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","article-title":"Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001","volume":"50","author":"Paolino","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2017.09.013_bib0130","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.0b013e3182904f96","article-title":"Fatal adenovirus encephalomyeloradiculitis in an umbilical cord stem cell transplant recipient","volume":"80","author":"Awosika","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jcv.2017.09.013_bib0135","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/bjd.14369","article-title":"Cutaneous involvement of disseminated adenovirus infection in an allogeneic stem cell transplant recipient","volume":"174","author":"Keyes","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jcv.2017.09.013_bib0140","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/tid.12582","article-title":"Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation","volume":"18","author":"Voigt","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.jcv.2017.09.013_bib0145","article-title":"Brincidofovir is highly efficacious in controlling adenoviremia in pediatric recipients of hematopoietic cell transplant","volume":"44","author":"Hiwarkar","year":"2017","journal-title":"Blood"},{"issue":"January (1)","key":"10.1016\/j.jcv.2017.09.013_bib0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbmt.2015.08.019","article-title":"Adenovirus viremia in adult CD34(+) selected hematopoietic cell transplant recipients: low incidence and high clinical impact","volume":"22","author":"Lee","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.jcv.2017.09.013_bib0155","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbmt.2016.12.621","article-title":"Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial","volume":"23","author":"Grimley","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.jcv.2017.09.013_bib0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2007.00821.x","article-title":"Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning","volume":"78","author":"Kalpoe","year":"2007","journal-title":"Eur. J. Haematol."},{"issue":"10","key":"10.1016\/j.jcv.2017.09.013_bib0165","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/cid\/cis689","article-title":"Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults","volume":"55","author":"Sive","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"13","key":"10.1016\/j.jcv.2017.09.013_bib0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa1303688","article-title":"CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation","volume":"369","author":"Marty","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T00:31:54Z","timestamp":1535329914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653217302767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":34,"alternative-id":["S1386653217302767"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2017.09.013","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir \u2013 Case series and 10 year experience of management in an adult transplant cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}